08:30Join Fertility 2021 Online

08:45 – 09:50

MORNING PLENARY

Chair: Ian Aird, Chair of Programme Committee

08:45
09:00
Chairs’ opening remarks and introduction – Ian Aird, Chair of Programme Committee and Dr Jane Stewart, Chair, BFS
Howard Jacobs Lecture: Evidence-based fertility treatments – the promise, the reality… – Professor Cynthia (Cindy) Farquhar, University of Auckland and Fertility Plus, Auckland District Health Board, New Zealand
09:50Comfort break

10:00 – 11:15

UPDATE 1: Ovarian reserve – endogenous and exogenous determinants

Chair: Richard Lea, Programme Chair, SRF

10:00
10:20
10:40
11:00
Gestational nutrition influences on ovarian development – Dr Peter Smith, AgResearch, New Zealand
The changing follicular microenvironment during oocyte maturation – Dr Janet Pitman, Victoria University of Wellington, New Zealand
Adipokines are energy sensors involved in the ovarian reserve and ovarian functions – Dr Joëlle Dupont, INRAE, France
Q&A
11:15Comfort break

11:25 – 12:35

SHORT PAPERS 1: Clinical Short paper session including – BFS young clinician, nursing and Iwan Lewis Jones Prizes

Chair: Jane Stewart, Chair, BFS

8 minute talksFertility preservation in the NHS: a national assessment of care policies for cryopreservation of oocytes, sperm and embryos – Sania Latif, University College London Hospitals NHS Foundation Trust
Follicular fluid levels of IL-10 influence fertilisation and early embryo development – Lucia Hartigan, Merrion Fertility Clinic and University College Dublin
Pregnancy outcome in Turner syndrome – Elizabeth Burt, University College London Hospital
Nurse sedation service for assisted reproduction procedures – a patient centred approach – Jennifer Ulyatt, NHS Tayside
Genitourinary infections on sperm DNA fragmentation in men with infertility – Carmen Ho, Imperial College London
A comparison of outcome of ICSI with epididymal and testicular sperm – a decade of nationwide data – Jonathan Lewin, University College London Hospital/NMUH
Q&A
12:35 – 13:30Lunch break

12:40-13:25

Platinum Sponsor’s symposium: Guerbet

12:40-13:25

The role of Oil-Soluble Contrast Medium Hysterosalpingography (OSCM-HSG) during the fertility work-up
Chair: Professor Anne Hemingway, UK

UK experience: Practical aspects & technical tips, fallopian tubes recanalization (FTR) – Dr Elika Kashef, UK

Pregnancy & live birth outcomes after HSG with OSCM: How does the clinical evidence impact fertility management? – Dr Velja Mijatovic, The Netherlands

13:30 – 14:45

UPDATE 2: Endometriosis and adenomyosis

Chair: Stuart Lavery, Programme Committee, BFS

13:30
13:50
14:10
14:30
Does surgery improve fertility in women with endometriosis – Professor Christian Becker, Nuffield Department of Women’s and Reproductive Health, UK
Endometriosis fertility index – ART after surgery, who and when – Professor Dr Carla Tomessitti, University Hospitals Leuven and KULeuven, Belgium
Recent advances in diagnosing and managing adenomyosis outcomes – Silvia Vannuccini, University of Florence, Italy
Q&A
14:45Comfort break

15:00 – 16:10

UPDATE 3: Obstetric complications of ART

Chair: Stuart Lavery, Programme Committee, BFS

15.00
15:20
15:40
16:00
Is it time to screen for cardiometabolic factors prior to ART – Professor Catherine Nelson-Piercy, Guy’s & St Thomas’ Foundation Trust
The challenge of assessing maternal-child health after IVF – the US experience – Professor Barbara Luke, Michigan State University, USA
Hypertensive disorders in pregnancies conceived using in vitro fertilisation – Professor Valerie L Baker, Johns Hopkins University School of Medicine, USA
Q&A
16:10Comfort break

16:20 – 17:20

SHORT PAPERS 2: SP2 Oocytes and ovaries
Chair: Dr Suman Rice, Programme Committee, SRF

8 minute talksBOLL regulates distinct mRNA targets from DAZL in the human fetal ovary – Dr Roseanne Rosario, The University of Edinburgh, UK
Transforming growth factor beta signalling in neonatal mouse ovaries promotes transcriptional changes that defer primordial follicle activation by the downregulation of differentiation pathways – Amelia Parkin-Green, University of Sheffield, UK
Inflammasome-dependent inflammation contributes to follicle loss during murine ovarian ageing – Carolina Lliberos, Monash University, Australia
The impact of haematological conditions on anti-Müllerian hormone levels in females of reproductive age – Xulin Foo, University College London Hospitals NHS Foundation Trust, UK
Altered mitochondrial biogenesis in poor ovarian response patients – Carolina Andrés Santé, Tambre Fertility Clinic Madrid, Spain
Q&A
17:20Comfort break

17:30-18:45

PLENARY SESSION

Chair: Mr Ian Aird, Chair, Programme Committee, BFS

17:30
18:05
Breakthroughs in the biology of infertilityanimal models to clinical practice –  Dr Martin Matzuk, Baylor College of Medicine, USA
Differentiation of the human germline – towards in vitro gametogenesis – Professor Amander Clark, UCLA, USA

18:45-19:45

Gold Sponsor’s symposium: Merck
Recognising LH/FSH deficiency: The future of ART

NB. Q&A session available on live broadcast only

Welcome and introduction – Dr Dana Chuderland, Global Medical Director, Global Medical Affairs Fertility
The pathophysiology of LH: What do we know? – Professor Scott Nelson Muirhead Chair of Reproductive & Maternal Medicine, University of Glasgow, UK
Redefining LH/FSH deficiency: What does it mean in clinical practice? – Professor Carlo Alviggi, Associate Professor of Gynaecology & Obstetrics, University of Naples Federico II, Italy

20:00 – 20:30

Calming yoga